MabThera Targeted Therapies
MabThera for Second-Line or Relapsed Chronic Lymphocytic Leukaemia
MabThera (also known as rituxmab) is used to treat people with Chronic Lymphocytic Leukaemia. It is usually given in conjunction with chemotherapy.
MabThera as a Maintenance Treatment for Follicular Lymphoma
Mabthera is a targeted therapy which has been used in the treatment of people with Non-Hodgkin’s Lymphoma, in particular those with follicular lymphoma.